Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MNK-155
MNK-155
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint
Yahoo/Zacks
Sat, 09/6/14 - 09:20 am
Mallinckrodt
pain management
MNK-155
Mallinckrodt's Pain Drug Shows Efficacy in Phase 3
Drug Discovery and Development
Fri, 09/5/14 - 08:04 am
Mallinckrodt
painkillers
MNK-155
Mallinckrodt's NDA accepted by FDA, triggering $5M payment to Depomed
The Fly on the Wall
Wed, 05/28/14 - 09:34 am
Mallinckrodt
FDA
Depomed
MNK-155
Acuform